Core Insights - C4 Therapeutics, Inc. is participating in the 8th Annual Evercore Healthcare Conference from December 2-4, 2025, indicating its active engagement in the healthcare investment community [1][2] - The company focuses on advancing targeted protein degradation science to develop innovative medicines aimed at transforming patient outcomes [3] Company Overview - C4 Therapeutics is a clinical-stage biopharmaceutical company listed on Nasdaq under the ticker CCCC [3] - The company is dedicated to creating a new generation of medicines through targeted protein degradation, which aims to address difficult-to-treat diseases [3] - C4T utilizes its TORPEDO platform to design and optimize small-molecule medicines, enhancing the potential to overcome drug resistance and improve patient outcomes [3] Event Details - The fireside chat will take place on December 3, 2025, at 3:25 pm ET, with a live webcast available on the company's website [2] - An archived replay of the webcast will be accessible for approximately 90 days following the live event [2]